Zydus Cadila has approached India’s top drug regulator for restricted emergency approval of ZyCov-D, its three-dose Covid-19 vaccine. If granted, this would be the first DNA vaccine available in the world.
The company, which has also been evaluating the possibility of using a two-dose regimen of ZyCov-D, said that the immunogenicity results “had been found to be equivalent to the current three-dose regimen” — two doses of the vaccine were able to prompt an immune response that was just as good as the response in a three-dose regimen
Explore the profound effects of excessive screen time on your child’s behavior and development. Discover…
Discover how simple daily changes in your diet and lifestyle can significantly improve your heart…
This article explores the common misconception that brain tumours primarily affect older adults, revealing the…
The first-ever ovarian cancer vaccine is poised to change the landscape of women's health by…
As dengue and chikungunya cases rise in Delhi during the monsoon season, understanding prevention strategies…
Skincare is a significant concern for women (and increasingly, men), with the quest for perfect,…